Does Pro Re Nata Oral Medication Shorten Outburst Duration in Children?

Child Child, Preschool Hospitals, Psychiatric Humans Mental Disorders / psychology Prospective Studies

Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
02 2022
Historique:
received: 19 05 2021
revised: 02 09 2021
accepted: 27 09 2021
pubmed: 8 10 2021
medline: 19 3 2022
entrez: 7 10 2021
Statut: ppublish

Résumé

We report a prospective, naturalistic, institutional review board-approved study of 104 children ages 5-12 in a psychiatric hospital, of whom 59 were treated with oral PRN medications per parent/guardian-consent, given at nursing discretion, with physicians informed subsequently, and intramuscular STAT medication and/or seclusion/restraint/holds (S/R/H) in dangerous situations when oral medication failed. Intramuscular STAT medication and/or S/R/H were ordered by physicians with parents informed subsequently. The outcome of interest was the duration of the outburst and whether this differed by PRN medication.

Identifiants

DOI: 10.1016/j.jaac.2021.09.415 PMID: 34619290
pubmed: 34619290
pii: S0890-8567(21)01866-9
doi: 10.1016/j.jaac.2021.09.415
pii:
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

111-114.e3

Informations de copyright

Copyright © 2021 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Gabrielle A Carlson (GA)

Renaissance School of Medicine at Stony Brook University, New York. Electronic address: Gabrielle.Carlson@stonybrookmedicine.edu.

Lauren Spring (L)

Renaissance School of Medicine at Stony Brook University, New York.

Joseph E Schwartz (JE)

Renaissance School of Medicine at Stony Brook University, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Does Pro Re Nata Oral Medication Shorten...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Enfant d'âge préscolaire › Does Pro Re Nata Oral Medication Shorten...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Établissements de santé › Hôpitaux › Hôpitaux spécialisés › Hôpitaux psychiatriques › Does Pro Re Nata Oral Medication Shorten...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Does Pro Re Nata Oral Medication Shorten...
questionsmedicales.fr › Troubles mentaux › Does Pro Re Nata Oral Medication Shorten...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Does Pro Re Nata Oral Medication Shorten...